HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | KLOW Blend |
|---|---|
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 80mg |
| Documentation | Batch-linked COA + HPLC chromatogram + MS identity record for every production lot |
| Distribution scope | Research use, worldwide |
| Storage | Store lyophilized powder sealed at -20°C, protected from light and moisture; long-term storage at -20°C or below. After reconstitution keep refrigerated at 2-8°C and use within a short window. Avoid repeated freeze-thaw cycles. |
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | 1 kit (10 vials) | 3–7 days |
| Production lot | 200–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Supplied as a research-use peptide. Every quote confirms current-batch COA, purity, destination market and buyer track before invoicing.
Overview
KLOW Blend is a physical combination of four distinct research peptides — the copper tripeptide GHK-Cu, the gastric pentadecapeptide BPC-157, the thymosin-β4 fragment TB-500, and the tripeptide KPV. It is supplied as a single-vial format grouping four separately studied research targets (collagen remodeling, tissue-repair signaling, cell migration and inflammation modulation) rather than as one defined molecular entity.
Documentation
batch-linked COA, HPLC chromatogram and MS identity record for every production lot. Distribution scope confirmed before invoicing.
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
Mass spectrometry identity confirmation against the KLOW Blend reference profile.
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
The standard KLOW composition is GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg and KPV 10mg, blended to 80mg total per lyophilized vial. Custom ratios or alternate totals can be produced to specification on RFQ.
No. KLOW is a physical blend of four distinct peptides, so it has no single CAS number, molecular formula or molecular weight. We can supply authoritative per-component identifiers and documentation for GHK-Cu, BPC-157, TB-500 and KPV individually.
Per-component COA with HPLC purity and MS identity, plus water content, blend ratio verification, lot code and shipment paperwork. Document scope and current batch COA can be reviewed before order confirmation.
KLOW is offered as an 80mg neutral lyophilized vial with a standard MOQ of 1 kit (10 vials). Neutral labeling is default; custom labels, branded packaging and private-label OEM services are available on request.
Yes. It is supplied strictly for B2B, laboratory and research use — not for consumer use, therapeutic or diagnostic use. Buyers are responsible for confirming import and regulatory compliance in their destination market.
Related compounds